US Patent Issued to GENFIT on Jan. 28 for "Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation" (French Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,087, issued on Jan. 28, was assigned to GENFIT (Loos, France).

"Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation" was invented by Peggy Parroche (Loos, France) and Robert Walczak (Lille, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a combination product comprising (i) nitazoxanide (NTZ) or an analogue thereof, and (ii) a PPAR agonist, for use in the treatment of an immune diseases or inflammation."

The patent was filed on April 7, 2020, under Application No. 17/599,256.

*For further information, including images, charts and tables, please visit: http://patft....